Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study.
Collantes-Estevez E, Muñoz-Villanueva MC, Zarco P, Torre-Alonso JC, Gratacós J, González C, Sanmartí R, Cañete JD; Spanish Spondyloarthropathies Study Group. Collantes-Estevez E, et al. Rheumatology (Oxford). 2005 Dec;44(12):1555-8. doi: 10.1093/rheumatology/kei085. Epub 2005 Aug 23. Rheumatology (Oxford). 2005. PMID: 16118228 Clinical Trial.
High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study).
Navarro-Sarabia F, Fernández-Sueiro JL, Torre-Alonso JC, Gratacos J, Queiro R, Gonzalez C, Loza E, Linares L, Zarco P, Juanola X, Román-Ivorra J, Martín-Mola E, Sanmartí R, Mulero J, Diaz G, Armendáriz Y, Collantes E. Navarro-Sarabia F, et al. Rheumatology (Oxford). 2011 Oct;50(10):1828-37. doi: 10.1093/rheumatology/ker083. Epub 2011 Jun 23. Rheumatology (Oxford). 2011. PMID: 21700683 Clinical Trial.
Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report.
Collantes E, Zarco P, Muñoz E, Juanola X, Mulero J, Fernández-Sueiro JL, Torre-Alonso JC, Gratacós J, González C, Batlle E, Fernández P, Linares LF, Brito E, Carmona L. Collantes E, et al. Rheumatology (Oxford). 2007 Aug;46(8):1309-15. doi: 10.1093/rheumatology/kem084. Epub 2007 May 27. Rheumatology (Oxford). 2007. PMID: 17526930
Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study.
Collantes-Estévez E, Muñoz-Villanueva MC, Cañete-Crespillo JD, Sanmartí-Sala R, Gratacós-Masmitjá J, Zarco-Montejo P, Torre-Alonso JC, González-Fernández C. Collantes-Estévez E, et al. Ann Rheum Dis. 2003 Dec;62(12):1239-40. doi: 10.1136/ard.2002.004879. Ann Rheum Dis. 2003. PMID: 14644870 Free PMC article. Clinical Trial. No abstract available.
Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.
Torre-Alonso JC, Carmona L, Moreno M, Galíndez E, Babío J, Zarco P, Linares L, Collantes-Estevez E, Barrial MF, Hermosa JC, Coto P, Suárez C, Almodóvar R, Luelmo J, Castañeda S, Gratacós J. Torre-Alonso JC, et al. Rheumatol Int. 2017 Aug;37(8):1239-1248. doi: 10.1007/s00296-017-3702-9. Epub 2017 Apr 7. Rheumatol Int. 2017. PMID: 28389856
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes.
Julià A, Tortosa R, Hernanz JM, Cañete JD, Fonseca E, Ferrándiz C, Unamuno P, Puig L, Fernández-Sueiro JL, Sanmartí R, Rodríguez J, Gratacós J, Dauden E, Sánchez-Carazo JL, López-Estebaranz JL, Moreno-Ramírez D, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Vanaclocha F, Herrera E, Muñoz-Fernández S, González C, Roig D, Erra A, Acosta I, Fernández-Nebro A, Zarco P, Alonso A, López-Lasanta M, García-Montero A, Gelpí JL, Absher D, Marsal S. Julià A, et al. Hum Mol Genet. 2012 Oct 15;21(20):4549-57. doi: 10.1093/hmg/dds295. Epub 2012 Jul 19. Hum Mol Genet. 2012. PMID: 22814393
54 results